Imaging Recommendations for Diagnosis, Staging, and Management of Pediatric Solid Tumors

Vasundhara Smriti; Akshay D. Baheti; Sneha Shah; Sajid S. Qureshi; Nanadan Shetty; Kunal Gala; Suyash Kulkarni; Abhijit Raut; Veenita Kamble; Girish Chinnaswamy; Maya Prasad; Badira C. P; Mukta Ramadwar; Suryaveer Singh; Anuradha Shukla; Hirenkumar Panwala; Arpita Sahu; Laskar Siddharth; Tejas Kapadia

doi:10.1055/s-0042-1759507

Indian Journal of Medical and Paediatric Oncology, Table of Contents

CC BY 4.0 · Indian J Med Paediatr Oncol 2023; 44(01): 138-148
DOI: 10.1055/s-0042-1759507

Review Article

Imaging Recommendations for Diagnosis, Staging, and Management of Pediatric Solid Tumors

Vasundhara Smriti

¹Department of Radiodiagnosis and Imaging, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Akshay D. Baheti

¹Department of Radiodiagnosis and Imaging, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Sneha Shah

³Department of Nuclear Medicine and molecular imaging, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Sajid S. Qureshi

⁴Division of Pediatric Surgical Oncology, Department of Surgical Oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Nanadan Shetty

⁵Department of Opthalmology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Kunal Gala

²Department of Intervention Radiology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Suyash Kulkarni

²Department of Intervention Radiology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Abhijit Raut

⁶Department of Radiodiagnosis, Kokilaben Dhirubhai Ambani Hospital, Mumbai, Maharashtra, India

,

Veenita Kamble

⁶Department of Radiodiagnosis, Kokilaben Dhirubhai Ambani Hospital, Mumbai, Maharashtra, India

,

Girish Chinnaswamy

⁷Department of Pediatric Oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Maya Prasad

⁷Department of Pediatric Oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Badira C. P

⁷Department of Pediatric Oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Mukta Ramadwar

⁸Department of Pathology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Suryaveer Singh

¹Department of Radiodiagnosis and Imaging, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Anuradha Shukla

¹Department of Radiodiagnosis and Imaging, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Hirenkumar Panwala

⁹Department of Radiodiagnosis, SRCC Children's Hospital, Mumbai, Maharashtra, India

,

Arpita Sahu

¹Department of Radiodiagnosis and Imaging, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Laskar Siddharth

¹⁰Department of Radiation Oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Tejas Kapadia

¹¹Children's X-ray Department/Academic Unit of Paediatric Radiology, Royal Manchester Children's Hospital, Manchester, United Kingdom

› Author Affiliations

Abstract

Paediatric extra-cranial solid tumours are one of the common causes for paediatric malignancies. Lack of appropriate imaging at presentation, staging and for follow-up is a major challenge for paediatric solid tumours. We have reviewed the paediatric solid tumour imaging protocols suggested by the major oncological societies/groups around the world (mainly the SIOP – Society International Pediatric Oncology, and the COG – Children's Oncology Group). We have adapted some of those protocols to develop imaging recommendations for the diagnosis, staging and management of extra-cranial solid tumours based on the treatment protocols followed in India.

Keywords

hepatoblastoma - imaging guidelines - neuroblastoma - pediatric oncology - pediatric solid tumors - Wilm's tumor

Full Text

References

References
1 Bhakta N, Force LM, Allemani C. et al. Childhood cancer burden: a review of global estimates. Lancet Oncol 2019; 20 (01) e42-e53
2 Johnston WT, Erdmann F, Newton R, Steliarova-Foucher E, Schüz J, Roman E. Childhood cancer: Estimating regional and global incidence. Cancer Epidemiol 2021; 71 (Pt B): 101662
3 Kushner BH, Khakoo Y. Enigmatic entities: opsoclonus myoclonus ataxia syndrome linked to neuroblastoma. Lancet Child Adolesc Health 2018; 2 (01) 3-5
4 Maas MH, Cransberg K, van Grotel M, Pieters R, van den Heuvel-Eibrink MM. Renin-induced hypertension in Wilms tumor patients. Pediatr Blood Cancer 2007; 48 (05) 500-503
5 Yhoshu E, Lone YA, Mahajan JK, Singh UB. Hepatoblastoma with precocious puberty. J Indian Assoc Pediatr Surg 2019; 24 (01) 68-71
6 Schooler GR, Squires JH, Alazraki A. et al. Pediatric hepatoblastoma, hepatocellular carcinoma, and other hepatic neoplasms: Consensus Imaging Recommendations from American College of Radiology Pediatric Liver Reporting and Data System (LI-RADS) Working Group. Radiology 2020; 296 (03) 493-497
7 Callahan MJ, Cravero JP. Should I irradiate with computed tomography or sedate for magnetic resonance imaging?. Pediatr Radiol 2022; 52 (02) 340-344
8 Ng K, Mogul DB. Pediatric liver tumors. Clin Liver Dis 2018; 22 (04) 753-772
9 Czauderna P, Lopez-Terrada D, Hiyama E, Häberle B, Malogolowkin MH, Meyers RL. Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr 2014; 26 (01) 19-28
10 Spector LG, Birch J. The epidemiology of hepatoblastoma. Pediatr Blood Cancer 2012; 59 (05) 776-779
11 Towbin AJ, Meyers RL, Woodley H. et al. 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT). Pediatr Radiol 2018; 48 (04) 536-554
12 Agarwala S, Gupta A, Bansal D. et al. Management of hepatoblastoma: ICMR consensus document. Indian J Pediatr 2017; 84 (06) 456-464
13 Cunningham ME, Klug TD, Nuchtern JG. et al. Global disparities in Wilms tumor. J Surg Res 2020; 247: 34-51
14 Charlton J, Irtan S, Bergeron C, Pritchard-Jones K. Bilateral Wilms tumour: a review of clinical and molecular features. Expert Rev Mol Med 2017; 19: e8
15 Nelson MV, van den Heuvel-Eibrink MM, Graf N, Dome JS. New approaches to risk stratification for Wilms tumor. Curr Opin Pediatr 2021; 33 (01) 40-48
16 Qureshi SS, Kembhavi SA, Bhagat M. et al. Customized approach for upfront or delayed resection using radiological criteria in unilateral, nonmetastatic pediatric renal tumors: a prospective study. Pediatr Blood Cancer 2019; 66 (Suppl. 03) e27815
17 Qureshi SS, Bhagat M, Kazi M. et al. Standardizing lymph nodal sampling for Wilms tumor: a feasibility study with outcomes. J Pediatr Surg 2020; 55 (12) 2668-2675
18 Qureshi SS, Bhagat M, Smriti V. et al. Intravascular extension of Wilms tumor: Characteristics of tumor thrombus and their impact on outcomes. J Pediatr Urol 2021; 17 (01) 69.e1-69.e8
19 NCG guidelines. 2020. Paediatric hematolymphoid and solid tumours. Accessed November 07, 2022, at: https://tmc.gov.in/ncg/index.php/107-guidlines
20 Kembhavi SA, Qureshi S, Vora T. et al. Understanding the principles in management of Wilms' tumour: can imaging assist in patient selection?. Clin Radiol 2013; 68 (07) 646-653
21 Prasad M, Vora T, Agarwala S. et al. Management of Wilms tumor: ICMR consensus document. Indian J Pediatr 2017; 84 (06) 437-445
22 Shaikh F, Murray MJ, Amatruda JF. et al. Paediatric extracranial germ-cell tumours. Lancet Oncol 2016; 17 (04) e149-e162
23 Faure-Conter C, Rocourt N, Sudour-Bonnange H. et al. [Pediatric germ cell tumours]. Bull Cancer 2013; 100 (04) 381-391
24 Horton Z, Schlatter M, Schultz S. Pediatric germ cell tumors. Surg Oncol 2007; 16 (03) 205-213
25 Agarwala S, Mitra A, Bansal D. et al. Management of pediatric malignant germ cell tumors: ICMR consensus document. Indian J Pediatr 2017; 84 (06) 465-472
26 Dieckmann KP, Frey U, Lock G. Contemporary diagnostic work-up of testicular germ cell tumours. Nat Rev Urol 2013; 10 (12) 703-712
27 Feldman DR. State-of-the-art management of germ cell tumors. Am Soc Clin Oncol Educ Book 2018; 38 (38) 319-323
28 Matthay KK, Shulkin B, Ladenstein R. et al. Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force. Br J Cancer 2010; 102 (09) 1319-1326
29 Monclair T, Brodeur GM, Ambros PF. et al; INRG Task Force. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 2009; 27 (02) 298-303
30 Kembhavi SA, Shah S, Rangarajan V, Qureshi S, Popat P, Kurkure P. Imaging in neuroblastoma: An update. Indian J Radiol Imaging 2015; 25 (02) 129-136
31 Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma. J Nucl Med 2009; 50 (08) 1237-1243
32 Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 2014; 64 (02) 83-103
33 Ripperger T, Bielack SS, Borkhardt A. et al. Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. Am J Med Genet A 2017; 173 (04) 1017-1037
34 Skapek SX, Ferrari A, Gupta AA. et al. Rhabdomyosarcoma. Nat Rev Dis Primers 2019; 5 (01) 1
35 Arndt CAS, Bisogno G, Koscielniak E. Fifty years of rhabdomyosarcoma studies on both sides of the pond and lessons learned. Cancer Treat Rev 2018; 68: 94-101
36 Hibbitts E, Chi YY, Hawkins DS. et al. Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: a report from the Children's Oncology Group. Cancer Med 2019; 8 (14) 6437-6448
37 van Ewijk R, Schoot RA, Sparber-Sauer M. et al; Cooperative Weichteilsarkom Studiengruppe Imaging Group, the European Society of Paediatric Radiology Oncology Task Force and the European Paediatric Soft Tissue Sarcoma Study Group Imaging Committee. European guideline for imaging in paediatric and adolescent rhabdomyosarcoma - joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology. Pediatr Radiol 2021; 51 (10) 1940-1951
38 O JH, Lodge MA, Wahl RL. O JH. Practical PERCIST: a simplified guide to PET response criteria in solid tumors 1.0. Radiology 2016; 280 (02) 576-584
39 Accessed November 07, 2022, at: https://tmc.gov.in/tmh/pdf/EBM%202018-Guidelines%20for%20Paediatric%20Solid%20Tumours.pdf
40 Crist WM, Anderson JR, Meza JL. et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 2001; 19 (12) 3091-3102
41 Raney RB, Walterhouse DO, Meza JL. et al. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. J Clin Oncol 2011; 29 (10) 1312-1318
42 Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol 2009; 93 (09) 1129-1131
43 Rodriguez-Galindo C, Orbach DB, VanderVeen D. Retinoblastoma. Pediatr Clin North Am 2015; 62 (01) 201-223
44 Rangamani S, SathishKumar K, Manoharan N. et al. Paediatric retinoblastoma in India: evidence from the National Cancer Registry Programme. Asian Pac J Cancer Prev 2015; 16 (10) 4193-4198
45 Stathopoulos C, Lumbroso-Le Rouic L, Moll AC. et al. Current indications of secondary enucleation in retinoblastoma management: a position paper on behalf of the European Retinoblastoma Group (EURbG). Cancers (Basel) 2021; 13 (14) 3392

Supplementary Material

Supplementary Material